Sastasundar Ventures Limited has informed the Exchange about Disclosure under Reg 30(9) of SEBI (LODR) - Intimation by Sastasundar Healthbuddy Limited, material subsidiary regarding Outcome of its Board Meeting.
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Health X Platform Limited's material subsidiary Sastasundar Healthbuddy Limited (SHBL) board approved a Tripartite Agreement with the Company and Envision India Fund, a Mauritius-based qualified institutional buyer. This follows a Share Purchase Agreement dated 25 February 2026, under which Envision will acquire Mitsubishi Corporation's entire shareholding in SHBL, marking Mitsubishi's exit from the subsidiary. The Tripartite Agreement contemplates merging SHBL into Health X Platform Limited, with Envision's economic interest in the merged entity to remain the same as it held in SHBL before the merger. If the merger cannot be completed for any reason, a share swap arrangement is planned so Envision receives equivalent shares of HealthX in lieu of its SHBL holding. Envision has also been granted the right to appoint a non-voting board observer to SHBL, and in certain circumstances, a director to SHBL's board.
This is a significant restructuring event: a foreign institutional investor is entering the group through a Mauritius fund, replacing Japanese strategic investor Mitsubishi, and the subsidiary may be merged into the listed parent. Shareholders should watch for forthcoming disclosures on the merger structure, share swap or issuance ratio, valuation, and timeline, as these will determine any dilution and the post-deal shareholding pattern.